TCOM vs YUM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
TCOM exhibits strong financial health with a Piotroski F-Score of 7/9 and a very conservative Debt/Equity ratio of 0.18. The stock is significantly undervalued, trading at $55.01, which is well below its Graham Number of $77.43 and its growth-based intrinsic value of $206.21. Despite a bearish technical trend (0/100) and recent price weakness, the company's fundamental performance is exceptional, characterized by a 53.35% profit margin and 97.8% YoY earnings growth. The massive disconnect between the low P/E (7.87) and the strong growth profile suggests a high margin of safety.
Yum! Brands presents a compelling investment case supported by strong profitability, consistent earnings growth, and a favorable valuation relative to the Consumer Cyclical sector. Despite recent insider selling, the company continues to deliver robust operating margins (34.41%) and ROA (24.03%), outperforming sector averages in efficiency and margin discipline. The stock trades at a forward P/E of 24.51, below the sector’s 49.07 average, while offering a 1.91% dividend yield with a sustainable 54.6% payout ratio. Analysts are aligned with a 'buy' recommendation and a $164.64 target, implying 10.5% upside, supported by accelerating YoY EPS growth of 17.0% and improving quarterly momentum.
Compare Another Pair
Related Comparisons
TCOM vs YUM: Head-to-Head Comparison
This page compares Trip.com Group Limited (TCOM) and Yum! Brands, Inc. (YUM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.